Profile data is unavailable for this security.
About the company
Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
- Revenue in INR (TTM)333.51m
- Net income in INR15.07m
- Incorporated2012
- Employees65.00
- LocationArvee Laboratories (India) Ltd403, Entice Building,, Opposite JayantilBRTS Bus Stop,, Iskcon Bopal Road, AmblIAHMEDABAD 380058IndiaIND
- Phone+91 2 717430479
- Fax+91 7 926742600
- Websitehttp://arveelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ducol Organics & Colours Ltd | 754.05m | 44.29m | 1.72bn | 73.00 | 38.91 | 2.75 | 25.33 | 2.28 | 3.05 | 3.05 | 51.86 | 43.15 | 0.7984 | 2.37 | 6.80 | 10,329,450.00 | 4.69 | -- | 6.23 | -- | 35.91 | -- | 5.87 | -- | 1.54 | 2.38 | 0.245 | -- | -16.89 | -- | -27.53 | -- | -- | -- |
| Jocil Ltd | 8.11bn | 24.35m | 1.75bn | 768.00 | 78.84 | -- | 20.42 | 0.2154 | 2.49 | 2.49 | 881.00 | -- | -- | -- | -- | 10,556,860.00 | -- | 3.60 | -- | 4.48 | 19.45 | 13.76 | 0.3003 | 1.31 | -- | 0.3009 | -- | 23.71 | -18.07 | 13.36 | -82.72 | -11.46 | 0.2443 | 8.45 |
| Vital Chemtech Ltd | 982.74m | -13.02m | 1.78bn | 70.00 | -- | 2.11 | 133.92 | 1.81 | -0.5568 | -0.5568 | 41.03 | 35.21 | 0.7143 | 5.78 | 2.54 | 14,039,110.00 | -0.9466 | -- | -1.22 | -- | 23.18 | -- | -1.33 | -- | 1.24 | -1.95 | 0.2341 | -- | -15.82 | -- | -116.18 | -- | -- | -- |
| Arvee Laboratories (India) Ltd | 333.51m | 15.07m | 1.95bn | 65.00 | 129.97 | -- | 65.95 | 5.85 | 1.36 | 1.36 | 30.16 | -- | -- | -- | -- | 5,130,949.00 | -- | 6.67 | -- | 10.12 | 48.21 | 37.16 | 4.52 | 5.63 | -- | 7.95 | -- | -- | -50.54 | -11.18 | -74.46 | -14.21 | 11.47 | -- |
| Signet Industries Ltd | 11.77bn | 123.76m | 2.09bn | 400.00 | 18.05 | -- | 9.46 | 0.1778 | 3.94 | 3.94 | 219.40 | -- | -- | -- | -- | 29,421,520.00 | -- | 1.66 | -- | 4.46 | 16.17 | 16.31 | 1.08 | 1.22 | -- | 1.24 | -- | 12.83 | 19.20 | 4.45 | 18.91 | 1.90 | -5.12 | 0.00 |
| Aeron Composite Ltd | -100.00bn | -100.00bn | 2.18bn | 433.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 65.58 | -- | 82.58 | -- | -- | -- |
